| Tumor-infiltrating lymphocyte therapy or ipilimumab in advanced melanoma MW Rohaan, TH Borch, JH Van Den Berg, Ö Met, R Kessels, ... New England Journal of Medicine 387 (23), 2113-2125, 2022 | 324 | 2022 |
| Efficacy and safety of on-demand use of 2 treatments designed for different etiologies of female sexual interest/arousal disorder: 3 randomized clinical trials A Tuiten, K van Rooij, J Bloemers, C Eisenegger, J van Honk, R Kessels, ... The journal of sexual medicine 15 (2), 201-216, 2018 | 64 | 2018 |
| MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial MW Rohaan, R Gomez-Eerland, JH Van Den Berg, MHG Foppen, ... Immuno-Oncology and Technology 15, 100089, 2022 | 23 | 2022 |
| LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial J Haanen, M Rohaan, TH Borch, JH Van den Berg, Ö Met, MG Foppen, ... Annals of Oncology 33, S1406, 2022 | 22 | 2022 |
| Cancer-related fatigue in relation to chronotype and sleep quality in (non-) Hodgkin lymphoma survivors DEJ Starreveld, GEA Habers, HB Valdimarsdottir, R Kessels, LA Daniëls, ... Journal of Biological Rhythms 36 (1), 71-83, 2021 | 22 | 2021 |
| The dosimetric and clinical advantages of the GTV-CTV-PTV margins reduction by 6 mm in head and neck squamous cell carcinoma: Significant acute and late toxicity reduction A Al-Mamgani, R Kessels, T Janssen, A Navran, S van Beek, C Carbaat, ... Radiotherapy and Oncology 168, 16-22, 2022 | 16 | 2022 |
| Randomized controlled trial to identify the optimal radiotherapy scheme for palliative treatment of incurable head and neck squamous cell carcinoma A Al-Mamgani, R Kessels, CG Verhoef, A Navran, O Hamming-Vrieze, ... Radiotherapy and Oncology 149, 181-188, 2020 | 16 | 2020 |
| Methods for assessing and controlling placebo effects R Kessels, R Mozer, J Bloemers Statistical Methods in Medical Research 28 (4), 1141-1156, 2019 | 15 | 2019 |
| Reduction of GTV to high-risk CTV radiation margin in head and neck squamous cell carcinoma significantly reduced acute and late radiation-related toxicity with comparable outcomes A Al-Mamgani, R Kessels, A Navran, O Hamming-Vrieze, CL Zuur, ... Radiotherapy and Oncology 162, 170-177, 2021 | 14 | 2021 |
| MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study A van der Voort, FM Louis, MS van Ramshorst, R Kessels, IA Mandjes, ... The Lancet Oncology 25 (5), 603-613, 2024 | 13 | 2024 |
| Genotype scores predict drug efficacy in subtypes of female sexual interest/arousal disorder: a double-blind, randomized, placebo-controlled cross-over trial A Tuiten, F Michiels, KBE Böcker, D Höhle, J van Honk, RPJ de Lange, ... Women's Health 14, 1745506518788970, 2018 | 13 | 2018 |
| ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study MAC Vermunt, DGJ Robbrecht, LA Devriese, JM Janssen, B Thijssen, ... Cancer Reports 4 (4), e1367, 2021 | 12 | 2021 |
| Conversion of unresponsiveness to immune checkpoint inhibition by fecal microbiota transplantation in patients with metastatic melanoma: study protocol for a randomized phase … JSW Borgers, FH Burgers, EM Terveer, ME Van Leerdam, CM Korse, ... BMC cancer 22 (1), 1366, 2022 | 11 | 2022 |
| The Sexual Event Diary (SED): development and validation of a standardized questionnaire for assessing female sexual functioning during discrete sexual events Y van Nes, J Bloemers, PGM van der Heijden, K van Rooij, J Gerritsen, ... The Journal of Sexual Medicine 14 (11), 1438-1450, 2017 | 10 | 2017 |
| Psychometric properties of the sexual event diary in a sample of Dutch women with female sexual interest/arousal disorder Y van Nes, J Bloemers, R Kessels, PGM Van Der Heijden, K van Rooij, ... The journal of sexual medicine 15 (5), 722-731, 2018 | 9 | 2018 |
| The Trial within Cohorts (TwiCs) study design in oncology: experience and methodological reflections R Kessels, AM May, M Koopman, KCB Roes BMC Medical Research Methodology 23 (1), 117, 2023 | 8 | 2023 |
| Retrospective Analyses of 18FDG-PET/CT Thyroid Incidentaloma in Adults: Incidence, Treatment, and Outcome in a Tertiary Cancer Referral Center MW Piek, JP de Boer, MR Vriens, RS van Leeuwaarde, M Stokkel, ... Thyroid 31 (11), 1715-1722, 2021 | 7 | 2021 |
| Trends in use and perceptions about triplet chemotherapy plus bevacizumab for metastatic colorectal cancer SC van Nassau, MJ Bond, I Scheerman, J Van Breeschoten, R Kessels, ... JAMA network open 4 (9), e2124766-e2124766, 2021 | 7 | 2021 |
| Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study) A Al-Mamgani, R Kessels, ZAR Gouw, A Navran, V Mohan, ... Clinical and translational radiation oncology 43, 100676, 2023 | 6 | 2023 |
| A multilevel structural equation model for assessing a drug effect on a patient‐reported outcome measure in on‐demand medication data R Kessels, M Moerbeek, J Bloemers, PG Van Der Heijden Biometrical Journal 63 (8), 1652-1672, 2021 | 5 | 2021 |
